Sidley Austin LLP advised GlaxoSmithKline plc on the deal. GlaxoSmithKline plc (GSK) announced the refinancing of its core revolving credit facilities consisting of US$2.5 billion of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
